Archives

The CenterWatch Monthly, June 2013

Monday, June 3, 2013 09:24 AM

Operating environment spurs out-of-the-box ideas

More... »

FDA approves two GSK oral oncology treatments

Friday, May 31, 2013 11:31 AM

GlaxoSmithKline, a research-based pharmaceutical and healthcare company, announced the FDA has approved both Tafinlar (dabrafenib) and Mekinist (trametinib).

More... »

Indiana Biosciences Research Institute opens doors

Friday, May 31, 2013 11:18 AM

The new Indiana Biosciences Research Institute opened its doors as the first industry-led collaborative life sciences research institute in the U.S.

More... »

Biogen Idec, WPI to develop programs for BETC

Friday, May 31, 2013 10:50 AM

Global biotechnology company Biogen Idec has signed a collaboration agreement with Worcester Polytechnic Institute (WPI) to develop and deliver programs at the university’s Biomanufacturing Education and Training Center (BETC) of Worcester, Mass.

More... »

Novotech expands partnership with Medidata Solutions

Friday, May 31, 2013 10:26 AM

Novotech, an Australia-based CRO, has expanded its relationship with Medidata Solutions, a global provider of cloud-based clinical development solutions, by achieving accreditation for Medidata Rave, a system for electronic data capture (EDC) and clinical data management (CDM).

More... »

LLS, Valor Biotherapeutics partner to advance novel therapy

Thursday, May 30, 2013 04:18 PM

The Leukemia & Lymphoma Society (LLS), a global voluntary health agency,  is committing approximately $6 million to Valor Biotherapeutics, a joint venture of biotechnology companies ImmunGene and Caliber, to co-fund the completion of preclinical development, manufacturing and a phase I clinical trial for a novel fusion protein that may change the poor outcomes faced by many patients with indolent lymphomas who do not respond to standard therapy with rituximab.

More... »

Department of Defense awards $2 million to spinal cord injury research

Thursday, May 30, 2013 04:11 PM

The Christopher & Dana Reeve Foundation and Capstone National Partners announced a $2 million grant from the Department of Defense (DOD) to further support the expansion of translational research to find treatments for individuals living with spinal cord injury, including servicemen and women.

More... »

AstraZeneca awarded grant by The Michael J. Fox Foundation

Thursday, May 30, 2013 03:50 PM

The Michael J. Fox Foundation for Parkinson's Research (MJFF) awarded global biopharmaceutical AstraZeneca (AZ) a grant to support research on levodopa-induced dyskinesias (LID), a complication of therapies commonly used to reduce Parkinson's disease symptoms.

More... »

FDA lifts clinical hold on anthrax vaccine program

Thursday, May 30, 2013 03:24 PM

PharmAthene, a biodefense company developing medical countermeasures against biological and chemical threats, said the FDA has lifted the clinical hold previously placed on a proposed phase II study of SparVax, a next generation recombinant anthrax vaccine.

"Anthrax has been identified as one of the foremost potential biological threats to the nation,” said Eric I. Richman, president and CEO.  “The U.S. government's requirement for a recombinant anthrax vaccine for the civilian Strategic National Stockpile is an important national security imperative that remains unfilled. Next-generation anthrax vaccines like SparVax, which employ modern vaccine technology, offer the potential for improved convenience, cost-effectiveness, more rapid immunity, and the ability for large scale rapid delivery.”

More... »

GenVec, Naval Medical Research Center enter $3.5 million contract

Thursday, May 30, 2013 03:19 PM

GenVec, a biopharmaceutical company focused on therapeutics and vaccines, has signed an agreement worth approximately $3.5 million with the Naval Medical Research Center (NMRC) to support malaria vaccine development. 

More... »